HY-133
- Generic Name
- HY-133
First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 52
- Registration Number
- NCT06290557
- Locations
- 🇩🇪
Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany
🇩🇪Department of Dermatology, Tübingen, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath